fibrinogen has been researched along with Minimal Disease, Residual in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, J; Liu, C; Liu, X; Man, YN; Wang, YN; Wu, XZ; Zhu, C | 1 |
| Concin, N; Grimm, C; Hefler, L; Hefler-Frischmuth, K; Husslein, H; Leipold, H; Marth, C; Polterauer, S; Reinthaller, A; Seebacher, V; Tempfer, C; Tomovski, C | 1 |
2 other study(ies) available for fibrinogen and Minimal Disease, Residual
| Article | Year |
|---|---|
Pretreatment plasma D-dimer, fibrinogen, and platelet levels significantly impact prognosis in patients with epithelial ovarian cancer independently of venous thromboembolism.
Topics: Adult; Aged; Aged, 80 and over; Blood Platelets; Cystadenocarcinoma, Serous; Disease Progression; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Follow-Up Studies; Humans; Middle Aged; Neoplasm Grading; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Prevalence; Prognosis; Survival Rate; Venous Thromboembolism | 2015 |
Plasma fibrinogen levels and prognosis in patients with ovarian cancer: a multicenter study.
Topics: Age Factors; Analysis of Variance; Antigens, Neoplasm; Biomarkers, Tumor; C-Reactive Protein; Disease-Free Survival; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Middle Aged; Neoplasm Staging; Neoplasm, Residual; Ovarian Neoplasms; Prognosis; Proportional Hazards Models; Retrospective Studies | 2009 |